Cargando…
Pharmacological Treatment for Hepatopulmonary Syndrome
Aim. Hepatopulmonary syndrome is a pulmonary dysfunction in the context of liver cirrhosis characterized by arterial deoxygenation. Affected patients have increased morbidity and mortality, and many of them expire before undergoing liver transplantation. Therefore, finding medical therapy as a bridg...
Autores principales: | Eshraghian, Ahad, Kamyab, Amir A'lam, Yoon, Seung Kew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3786536/ https://www.ncbi.nlm.nih.gov/pubmed/24102057 http://dx.doi.org/10.1155/2013/670139 |
Ejemplares similares
-
Hepatopulmonary syndrome
por: Raevens, Sarah, et al.
Publicado: (2022) -
THE HEPATOPULMONARY SYNDROME
por: NACIF, Lucas Souto, et al.
Publicado: (2014) -
The effects of flavanoid on the treatment of hepatopulmonary syndrome
por: Atalay, Talha, et al.
Publicado: (2013) -
Current concepts in the management of hepatopulmonary syndrome
por: Ho, Vincent
Publicado: (2008) -
Hepatopulmonary syndrome: An update
por: Gandhi, Kejal D, et al.
Publicado: (2021)